Familial Pancreatic Cancer: Current Perspectives

Area of Science:

• Oncology
• Genetics
• Preventive Medicine

Background:

• Pancreatic cancer (PC) has a low survival rate, often due to late diagnosis, rapid progression, and poor treatment response.
• Approximately 10% of PC cases have a familial basis, with inherited cancer syndromes accounting for 3% and familial pancreatic cancer (FPC) for 7% without identified mutations.

Purpose of the Study:

• To review current strategies and implications for genetic counseling, surveillance, and therapeutic interventions in hereditary and familial pancreatic cancer.
• To highlight the importance of identifying high-risk individuals for pancreatic cancer for preventive and early detection measures.

Main Methods:

• Review of current literature on hereditary pancreatic cancer and familial pancreatic cancer.
• Analysis of evidence supporting genetic germline analysis and pancreatic screening in high-risk individuals.

Main Results:

• Increasing evidence supports the benefit of genetic germline analysis in PC patients.
• Periodic pancreatic screening is recommended for high-risk patients, particularly those with a lifetime risk exceeding 5%.

Conclusions:

• Genetic counseling and germline analysis are vital for managing hereditary and familial pancreatic cancer.
• Further consensus is needed on patient selection for genetic testing and screening protocols to improve pancreatic cancer outcomes.